Research and Clinical Trials

Title  

Cy4031

Brief Description  

The research study involves an investigational drug called tirasemtiv which is being investigated as a potential new therapy for the improvement of muscle weakness and muscle fatigue in patients with ALS (Amyotrophic Lateral Sclerosis). The purpose of the study is to assess the effect of tirasemtiv versus placebo on respiratory function but will also evaluate the safety, tolerability and efficacy of tirasemtiv when taken with or without riluzole. Time will be 60 weeks, 16 study visits.

Who may be Eligible  

Patients with familial or sporadic ALS diagnosed =24 months prior to screening who are =18 years of age.

Start Date  

08/31/2015

IRB Number  

08-15-14B

Principal Investigator  

Brooks, Benjamin

Contact Name  

Cynthia

For More Information, Contact  Cynthia  , Lary
Phone:  (704) 446-6063  Fax:  (704) 446-1915  
Email:  cynthia.lary@atriumhealth.org
Address:Neurosciences Institute, Neurology-Charlotte 1010 Edgehill Road North Charlotte, NC 28207